Chest pain other diagnostic studies: Difference between revisions
Line 23: | Line 23: | ||
! style="width: 200px; background: #4479BA;" | {{fontcolor|#FFF| Exercise ECG}} | ! style="width: 200px; background: #4479BA;" | {{fontcolor|#FFF| Exercise ECG}} | ||
! style="width: 300px; background: #4479BA;" | {{fontcolor|#FFF|Stress Nuclear}} | ! style="width: 300px; background: #4479BA;" | {{fontcolor|#FFF|Stress Nuclear}} | ||
! style="width: 400px; background: #4479BA;" | {{fontcolor|#FFF| | ! style="width: 400px; background: #4479BA;" | {{fontcolor|#FFF|Stress Echocardiography}} | ||
! style="width: 300px; background: #4479BA;" | {{fontcolor|#FFF| | ! style="width: 300px; background: #4479BA;" | {{fontcolor|#FFF|Stress CMR}} | ||
! style="width: 400px; background: #4479BA;" | {{fontcolor|#FFF|600px}} | ! style="width: 400px; background: #4479BA;" | {{fontcolor|#FFF|600px}} | ||
|- | |- | ||
Line 34: | Line 34: | ||
*Limited [[acoustic]] windows (in [[COPD]] [[patients]]) | *Limited [[acoustic]] windows (in [[COPD]] [[patients]]) | ||
*Inability to reach target [[heart rate]] | *Inability to reach target [[heart rate]] | ||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Reduced [[GFR]] (<30 mL/min/1.73 m2) | ||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | The width of this column is 600px | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | The width of this column is 600px | ||
|- | |- | ||
Line 43: | Line 43: | ||
* Contraindications to [[vasodilator]] administration | * Contraindications to [[vasodilator]] administration | ||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Uncontrolled [[heart failure]] | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Uncontrolled [[heart failure]] | ||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Contraindications to [[vasodilator]] administration | ||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | The width of this column is 600px | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | The width of this column is 600px | ||
|- | |- | ||
Line 53: | Line 53: | ||
* High-risk [[unstable angina]], active [[ACS]] or [[AMI]] (<2 d) | * High-risk [[unstable angina]], active [[ACS]] or [[AMI]] (<2 d) | ||
* Serious [[ventricular arrhythmia]] or high risk for [[arrhythmias]] attributable to [[QT prolongation]] | * Serious [[ventricular arrhythmia]] or high risk for [[arrhythmias]] attributable to [[QT prolongation]] | ||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Avoiding [[CMR]] in the presence of implanted device due to producing artifact limiting scan quality interpretatrion | ||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | The width of this column is 600px | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | The width of this column is 600px | ||
|- | |- | ||
Line 63: | Line 63: | ||
* [[Respiratory failure]] | * [[Respiratory failure]] | ||
*Severe [[COPD]], acute [[pulmonary embolism]], severe [[pulmonary hypertension]] | *Severe [[COPD]], acute [[pulmonary embolism]], severe [[pulmonary hypertension]] | ||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Significant [[claustrophobia]] | ||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | The width of this column is 600px | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | The width of this column is 600px | ||
|- | |- | ||
Line 74: | Line 74: | ||
* Contraindications to [[dobutamine]] (if [[pharmacologic stress test]] needed) | * Contraindications to [[dobutamine]] (if [[pharmacologic stress test]] needed) | ||
* [[Atrioventricular block]], uncontrolled [[atrial fibrillation]] | * [[Atrioventricular block]], uncontrolled [[atrial fibrillation]] | ||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | [[Caffeine]] use within past 12 hours | ||
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | The width of this column is 600px | | style="padding: 0 5px; background: #F5F5F5; text-align: left;" | The width of this column is 600px | ||
|- | |- |
Revision as of 07:23, 24 December 2021
Chest pain Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Chest pain other diagnostic studies On the Web |
Risk calculators and risk factors for Chest pain other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Aisha Adigun, B.Sc., M.D.[3]
Overview
Invasive Coronary Angiography (ICA) is used to determine the presence and severity of a luminal obstruction of an epicardial coronary artery, including its location, length, and diameter, as well as coronary blood flow. ICA provides the characterization of high-grade obstructive stenosis and possibility for percutaneous or surgical revascularization. (IFR and FFR) provide physiologic characteristic of stenosis. Radiation exposure to the patient during an interventional procedure varied 4 to 10 mSv and is dependent on procedural duration and complexity. The spatial resolution of ICA is 0.3 mm; as such, it is impossible to visualize arterioles (diameter of 0.1 mm) that regulate myocardial blood flow. Coronary vascular functional studies can be performed during coronary angiography. In normal coronary angiography there may be evident abnormal coronary vascular function. Assessment of coronary microcirculation and coronary vasomotion by coronary function testing are reasonable.
Other Diagnostic Studies
- Invasive Coronary Angiography (ICA) is used to determine the presence and severity of a luminal obstruction of an epicardial coronary artery, including its location, length, and diameter, as well as coronary blood flow.
- ICA provides the characterization of high-grade obstructive stenosis and the possibility for percutaneous or surgical revascularization.
- (IFR and FFR) provide physiologic characteristic of stenosis.
- Radiation exposure to the patient during an interventional procedure varied 4 to 10 mSv and is dependent on procedural duration and complexity.
- The spatial resolution of ICA is 0.3 mm; as such, it is impossible to visualize arterioles (diameter of 0.1 mm) that regulate myocardial blood flow.
- Coronary vascular functional studies can be performed during coronary angiography.
- In normal coronary angiography there may be evidence of abnormal coronary vascular function.
- Assessment of coronary microcirculation and coronary vasomotion by coronary function testing are reasonable.
Contraindications of stress test for diagnosis of acute chest pain
Exercise ECG | Stress Nuclear | Stress Echocardiography | Stress CMR | 600px |
---|---|---|---|---|
|
|
|
Reduced GFR (<30 mL/min/1.73 m2) | The width of this column is 600px |
|
|
Uncontrolled heart failure | Contraindications to vasodilator administration | The width of this column is 600px |
|
|
|
Avoiding CMR in the presence of implanted device due to producing artifact limiting scan quality interpretatrion | The width of this column is 600px |
|
|
|
Significant claustrophobia | The width of this column is 600px |
|
|
|
Caffeine use within past 12 hours | The width of this column is 600px |
|
|
|
The width of this column is 500px | The width of this column is 600px |
|
|
The width of this column is 500px | The width of this column is 600px |